Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs INDOCO REMEDIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA INDOCO REMEDIES SANOFI INDIA/
INDOCO REMEDIES
 
P/E (TTM) x 31.3 30.0 104.3% View Chart
P/BV x 15.6 2.9 528.2% View Chart
Dividend Yield % 7.0 0.7 1,015.0%  

Financials

 SANOFI INDIA   INDOCO REMEDIES
EQUITY SHARE DATA
    SANOFI INDIA
Dec-22
INDOCO REMEDIES
Mar-23
SANOFI INDIA/
INDOCO REMEDIES
5-Yr Chart
Click to enlarge
High Rs7,939423 1,876.4%   
Low Rs5,454308 1,771.1%   
Sales per share (Unadj.) Rs1,202.8181.1 664.3%  
Earnings per share (Unadj.) Rs269.515.4 1,745.6%  
Cash flow per share (Unadj.) Rs287.723.1 1,245.4%  
Dividends per share (Unadj.) Rs570.002.25 25,333.3%  
Avg Dividend yield %8.50.6 1,382.8%  
Book value per share (Unadj.) Rs527.0111.5 472.6%  
Shares outstanding (eoy) m23.0392.15 25.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.62.0 275.8%   
Avg P/E ratio x24.923.7 105.0%  
P/CF ratio (eoy) x23.315.8 147.1%  
Price / Book Value ratio x12.73.3 387.7%  
Dividend payout %211.514.6 1,451.3%   
Avg Mkt Cap Rs m154,22433,683 457.9%   
No. of employees `000NANA-   
Total wages/salary Rs m4,0593,226 125.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m27,70116,686 166.0%  
Other income Rs m73024 3,062.1%   
Total revenues Rs m28,43116,710 170.1%   
Gross profit Rs m8,3492,860 291.9%  
Depreciation Rs m419706 59.3%   
Interest Rs m17250 6.8%   
Profit before tax Rs m8,6431,928 448.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,437505 482.2%   
Profit after tax Rs m6,2061,423 436.3%  
Gross profit margin %30.117.1 175.8%  
Effective tax rate %28.226.2 107.6%   
Net profit margin %22.48.5 262.8%  
BALANCE SHEET DATA
Current assets Rs m36,1218,082 446.9%   
Current liabilities Rs m27,4254,245 646.0%   
Net working cap to sales %31.423.0 136.5%  
Current ratio x1.31.9 69.2%  
Inventory Days Days11725 465.3%  
Debtors Days Days17768 2.2%  
Net fixed assets Rs m12,1489,055 134.2%   
Share capital Rs m230184 124.8%   
"Free" reserves Rs m11,90610,092 118.0%   
Net worth Rs m12,13610,276 118.1%   
Long term debt Rs m01,435 0.0%   
Total assets Rs m48,27917,137 281.7%  
Interest coverage x509.48.7 5,853.4%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.61.0 58.9%   
Return on assets %12.99.8 132.0%  
Return on equity %51.113.8 369.4%  
Return on capital %71.418.6 383.6%  
Exports to sales %14.147.5 29.7%   
Imports to sales %14.611.5 126.8%   
Exports (fob) Rs m3,9047,919 49.3%   
Imports (cif) Rs m4,0371,917 210.5%   
Fx inflow Rs m3,9047,919 49.3%   
Fx outflow Rs m4,0371,917 210.5%   
Net fx Rs m-1336,002 -2.2%   
CASH FLOW
From Operations Rs m3,9871,788 222.9%  
From Investments Rs m6,509-2,082 -312.7%  
From Financial Activity Rs m-15,827228 -6,940.4%  
Net Cashflow Rs m-5,331-65 8,162.6%  

Share Holding

Indian Promoters % 0.0 58.7 -  
Foreign collaborators % 60.4 0.0 -  
Indian inst/Mut Fund % 28.8 21.3 135.6%  
FIIs % 6.3 1.7 373.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 41.3 96.0%  
Shareholders   62,870 32,600 192.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Sanofi India vs Indoco Remedies

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Sanofi India vs Indoco Remedies Share Price Performance

Period Sanofi India Indoco Remedies S&P BSE HEALTHCARE
1-Day 3.07% -1.82% 1.18%
1-Month -7.18% -6.45% -0.75%
1-Year 45.88% 1.09% 61.82%
3-Year CAGR 1.30% 4.71% 18.16%
5-Year CAGR 7.28% 11.97% 19.79%

* Compound Annual Growth Rate

Here are more details on the Sanofi India share price and the Indoco Remedies share price.

Moving on to shareholding structures...

The promoters of Sanofi India hold a 60.4% stake in the company. In case of Indoco Remedies the stake stands at 58.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Sanofi India and the shareholding pattern of Indoco Remedies.

Finally, a word on dividends...

In the most recent financial year, Sanofi India paid a dividend of Rs 570.0 per share. This amounted to a Dividend Payout ratio of 211.5%.

Indoco Remedies paid Rs 2.3, and its dividend payout ratio stood at 14.6%.

You may visit here to review the dividend history of Sanofi India, and the dividend history of Indoco Remedies.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.